Evidence of different profiles of side effects and drug-drug interactions among the quinolones - The pharmacokinetic standpoint

Chemotherapy

Volumn 47, Issue SUPPL. 3, 2001, Pages 24-31

  Lode, Hartmut ^a,b  

^a Institute of Pathology   (Germany)

^b Department of Chest and Infectious Diseases   (Germany)

Author keywords

ADRs; Drug drug interactions; Fluoroquinolones; Levofloxacin; Pharmacokinetics; Safety

Indexed keywords

CATION; CIPROFLOXACIN; ENOXACIN; GATIFLOXACIN; GEMIFLOXACIN; IRON DERIVATIVE; LEVOFLOXACIN; MOXIFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; THEOPHYLLINE; TROVAFLOXACIN;

ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; CONFERENCE PAPER; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG EXCRETION; DRUG METABOLISM; DRUG SAFETY; HUMAN; PHOTOTOXICITY; PRIORITY JOURNAL; QT INTERVAL;

EID: 0034846891     PISSN: 00093157     EISSN: None     Source Type: Journal    
DOI: 10.1159/000057841     Document Type: Conference Paper

References (9)

1. Pharmacokinetics and pharmacodynamics of the fluoroquinolones
2. Comparative pharmacokinetics of ciprofloxacin, gatifloxacin, grepafloxacin, levofloxacin, trovafloxacin, and moxifloxacin after single oral administration in healthy volunteers
3. Pharmacokinetic profile of levofloxacin following once-daily 500-milligram oral or intravenous doses
4. Safety overview: Toxicity, adverse effects, and drug interactions
5. Reduced enteral absorption of ciprofloxacin in the presence of antacids
6. Fluoroquinolone antibiotics: Adverse effect and safety profiles
7. Fluoroquinolones: Interaction profile during enteral absorption
8. Comparative tolerability of the newer fluoroquinolone antibacterials
9. Achilles tendinitis associated with fluoroquinolones